RHYTHM PHARMACEUTICALS INC (RYTM) Institutional Ownership and Insiders Activity
RHYTHM PHARMACEUTICALS INC (RYTM) is widely held by institutional investors, with 300 firms reporting positions valued at approximately $8.46B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Ra Capital Management, L.P. is the largest disclosed holder, reporting approximately $740.22M in RYTM holdings in its latest filing.
Recent insider activity includes 26 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
300
Total Reported Value
$8.46B
Largest Holder
Ra Capital Management, L.P.
Largest Position
$740.22M
Insider Transactions (90d)
26
Latest Filing Quarter
Q2 2026
New Institutional Positions
60
Funds Exiting Positions
50
Top Institutional Owners
View all- Ra Capital Management, L.P.$740.22M
- Blackrock, Inc.$683.60M
- Baker Bros. Advisors Lp$622.27M
- Primecap Management Co/Ca/$351.84M
- Vanguard Portfolio Management Llc$348.29M
RYTM News
All news- Ra Capital Management Q2 2026 Portfolio Update: Strategic Shifts in Healthcare Focus
Aug 19, 2026 · valut.ai
- Perceptive Advisors Q2 2026 Portfolio Activity: Significant Buys and Sells in Biotech Stocks
Aug 19, 2026 · valut.ai
Related RYTM Institutional Insights:
- RYTM 13F Institutional Holders
- RYTM Superinvestors
- RYTM Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- RYTM Insider Trading & SEC Form 4 Activity
- RYTM Articles
- Top Institutional Investor Stock Rankings